omega-n-methylarginine has been researched along with Angina Pectoris, Variant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, K; Katsuda, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, T; Takeshita, A | 1 |
| Hirashima, O; Inobe, Y; Kawano, H; Kugiyama, K; Motoyama, T; Ogawa, H; Ohgushi, M; Soejima, H; Sugiyama, S; Yasue, H; Yoshimura, M | 1 |
2 other study(ies) available for omega-n-methylarginine and Angina Pectoris, Variant
| Article | Year |
|---|---|
Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
Topics: Aged; Angina Pectoris, Variant; Arginine; Coronary Vasospasm; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 1996 |
Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina.
Topics: Adenosine; Adult; Aged; Angina Pectoris, Variant; Case-Control Studies; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Echocardiography, Doppler; Electrocardiography; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Vasodilation; Vasodilator Agents | 1997 |